Procurement Sciences, the end-to-end AI growth platform for government contractors, announced the acquisition of Rogue AI, an AI-native innovator in proposal and workflow automation for the government ...
A colorectal cancer blood test candidate from Exact Sciences fell short in its pivotal study, but the company is still in the hunt to provide an alternative to the liquid biopsy that was first to ...
Family and consumer sciences professionals shape lives daily, support communities and quietly power some of the country’s most essential industries. For years, the value of that work has been clear to ...
Joel Mokyr, Philippe Aghion and Peter Howitt have been awarded the 2025 Nobel Prize in Economics. (Photo by Jonathan Nackstrand / AFP) / ALTERNATIVE CROP (Photo by JONATHAN NACKSTRAND/AFP via Getty ...
Gilead Sciences broke into the field of cancer cell therapies through an acquisition. Now it’s aiming to be part of the next generation of such therapies by buying clinical-stage Interius ...
The company best known for its Cologuard colon cancer screening test posted a loss of $86 million, or $0.45 per share, on ...
The subject area represents the next stage of the database’s evolution, and heralds other proposed changes to journal selection and article categorization. The first Nature Index tables in the applied ...
North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...
Recent Exact Sciences Corporation financials show accelerating revenue growth and stable margins, despite ongoing investments in screening and MRD. While EXAS maintains leadership in stool-based CRC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results